RXMD Stock Overview
Progressive Care, Inc., through its subsidiary, Pharmco, LLC, provides prescription pharmaceuticals to individuals and institutions in south Florida.
Progressive Care, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$0.039|
|52 Week High||US$0.061|
|52 Week Low||US$0.019|
|1 Month Change||-12.39%|
|3 Month Change||14.75%|
|1 Year Change||33.68%|
|3 Year Change||-29.14%|
|5 Year Change||141.62%|
|Change since IPO||-67.58%|
Recent News & Updates
|RXMD||US Consumer Retailing||US Market|
Return vs Industry: RXMD exceeded the US Consumer Retailing industry which returned 0.1% over the past year.
Return vs Market: RXMD exceeded the US Market which returned -20.6% over the past year.
|RXMD Average Weekly Movement||12.5%|
|Consumer Retailing Industry Average Movement||5.7%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.6%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: RXMD is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week.
Volatility Over Time: RXMD's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Progressive Care, Inc., through its subsidiary, Pharmco, LLC, provides prescription pharmaceuticals to individuals and institutions in south Florida. The company operates a retail pharmacy that specializes in the sale of anti-retroviral medications and related patient care management; the sale and rental of durable medical equipment (DME), such as hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories; and the supply of various prescription medications to long term care facilities. It also provides long term care solutions to skilled nursing facilities, assisted living facilities, retirement centers and communities, doctors’ offices, and clinics.
Progressive Care, Inc. Fundamentals Summary
|RXMD fundamental statistics|
Is RXMD overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|RXMD income statement (TTM)|
|Cost of Revenue||US$31.24m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.019|
|Net Profit Margin||-31.07%|
How did RXMD perform over the long term?See historical performance and comparison